Bokf Na Cuts Holdings in The Clorox Company (NYSE:CLX)

Bokf Na trimmed its position in The Clorox Company (NYSE:CLX) by 2.2% during the second quarter, Holdings Channel.com reports. The firm owned 18,918 shares of the company’s stock after selling 431 shares during the period. Bokf Na’s holdings in Clorox were worth $2,582,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. SG Americas Securities LLC lifted its position in shares of Clorox by 1,525.7% during the 1st quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock worth $10,046,000 after buying an additional 61,576 shares during the last quarter. Mizuho Markets Americas LLC boosted its stake in shares of Clorox by 93.7% during the first quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock worth $11,032,000 after buying an additional 34,864 shares during the period. CANADA LIFE ASSURANCE Co lifted its position in Clorox by 15.2% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock worth $21,705,000 after acquiring an additional 18,687 shares during the period. Advisors Asset Management Inc. grew its position in Clorox by 257.5% in the 1st quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock valued at $1,719,000 after buying an additional 8,087 shares during the last quarter. Finally, Game Plan Financial Advisors LLC purchased a new stake in shares of Clorox in the first quarter valued at about $1,025,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Trading Up 0.8 %

CLX opened at $166.26 on Friday. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $167.75. The firm has a market capitalization of $20.59 billion, a P/E ratio of 86.15, a P/E/G ratio of 3.29 and a beta of 0.40. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The firm’s 50 day moving average is $146.16 and its 200-day moving average is $143.38.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The company had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. Analysts expect that The Clorox Company will post 6.63 EPS for the current fiscal year.

Clorox Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Wednesday, August 14th were issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 2.94%. The ex-dividend date of this dividend was Tuesday, August 13th. This is an increase from Clorox’s previous quarterly dividend of $1.20. Clorox’s dividend payout ratio (DPR) is currently 252.85%.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft upped their price objective on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. BNP Paribas raised shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. Citigroup upped their target price on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Argus raised Clorox to a “hold” rating in a research note on Tuesday, June 4th. Finally, Wells Fargo & Company decreased their target price on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research report on Wednesday, July 10th. Six research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $143.50.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.51% of the stock is currently owned by company insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.